Microsoft Word - Final for LuLu Vol. 14 Issue 1 Final A. The burden of untreated pain. The importance of opioid therapy Potential pitfalls of opioid therapy The burden of untreated opioid addiction Medication assisted treatment Federal Regulation of MAT: Historical Context Federal Regulation of Methadone Federal Regulation of Buprenorphine Insurance Coverage of MAT Access to emergency overdose treatment Addressing legal and policy barriers to naloxone access 1. Immunity 2. Prescribing outside of the traditional prescriber relationship 3. Overdose Good Samaritan laws 4. Over-the-counter access http://doi.org/10.18060/3911.0027 A. The Burden of Untreated Pain Prevalence of Chronic Benign Pain Disorder Among Adults: A Review of the Literature Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity with Depression-Anxiety Disorders https://doi.org/10.1016/s0304-3959(98)00117-1 https://doi.org/10.1016/j.jpain.2008.05.005 supra AAPM Facts and Figures on Pain Back Pain Prevalence and Visit Rates: Estimates from U.S. National Surveys, 2002 supra supra Access to Therapeutic Opioids: A Plan of Action for Donors, NGOs, and Governments Persistent Postsurgical Pain: Risk Factors and Prevention Depression and Anxiety Associated with Three Pain Conditions: Results from a Nationally Representative Sample Cancer-Related Chronic Pain: Examining Quality of Life in Diverse Cancer Survivors The economic costs of pain in the United States A Systematic Review of Low Back Pain Cost of Illness Studies in the United States and Internationally Aging Baby Boomers and the Rising Cost of Chronic Back Pain: Ssecular Trend Analysis of Longitudinal Medical Expenditures Panel Survey Data for Years 2000 https://doi.org/10.1097/01.brs.0000244618.06877.cd https://doi.org/10.1016/s0140-6736(06)68700-x https://doi.org/10.1016/j.pain.2004.06.002 https://doi.org/10.1002/cncr.25761 https://doi.org/10.1016/j.jpain.2012.03.009 https://doi.org/10.1016/j.spinee.2007.10.005 B. The Importance of Opioid Therapy to 2007 Id. Opioid Therapy for Chronic Pain Postoperative Pain Experience: Results from a National Survey Suggest Postoperative Pain Continues to be Undermanaged supra See Opioid Pharmacology supra Basic Opioid Pharmacology: An Update supra supra supra supra https://doi.org/10.1016/j.jmpt.2012.12.001 http://doi.org/10.1056/NEJMra025411 https://doi.org/10.1213/01.ane.0000068822.10113.9e https://doi.org/10.1177/2049463712438493 supra supra supra Postoperative Pain Control Perspective on Pain Management in the 21st Century, Use of Opioid Analgesics in the Treatment of Cancer Pain: Evidence-Based Recommendations from the EAPC Prevalence of Pain in Patients with Cancer: A Systematic Review of the Past 40 Years Evidence-Based Pain Guidelines in HIV Care See See generally Breaking the Cycle of Preventable Suffering: Fulfilling the Principle of Balance Access to Pain Treatment as a Human Right http://doi.org/10.1055/s-0033-1351138 https://doi.org/10.1016/j.pmn.2007.11.002 https://doi.org/10.1016/S1470-2045(12)70040-2 https://doi.org/10.1093/annonc/mdm056 https://doi.org/10.1016/j.jana.2012.05.006 https://doi.org/10.1186/1741-7015-8-8 C. Potential Pitfalls of Opioid Therapy Pain Management: A Fundamental Human Right Monitoring Opioid Adherence in Chronic Pain Patients: Assessment of Risk of Substance Misuse 2014 Global Consumption of Oxycodone (mg/capita) Id. Id. The World Health Organization Paves the Way for Action to Free People From the Shackles of Pain Management of Pain in Elderly Patients with Cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology Time to Take Stock: A Meta-Analysis and Systematic Review of Analgesic Treatment Disparities for Pain in the United States https://doi.org/10.1213/01.ane.0000268145.52345.55 https://doi.org/10.1213/01.ane.0000267542.72315.34 http://doi.org/10.1001/jama.279.23.1877 https://doi.org/10.1111/j.1526-4637.2011.01310.x Vital Signs: Overdoses of Prescription Opioid Pain Relievers–United States, 1999-2008 Ambulatory Diagnosis and Treatment of Nonmalignant Pain in the United States, 2000-2010 Rising Opioid Prescribing in Adult U.S. Emergency Department Visits: 2001-2010 Opioids Compared to Placebo or Other Treatments for Chronic Low- Back Pain Comparative Clinical Effectiveness of Management Strategies for Sciatica: Systematic Review and Network Meta-Analyses Opioid Therapy for Treating Rheumatoid Arthritis Pain Oral or Transdermal Opioids for Osteoarthritis o f the Knee or Hip Combining Ibuprofen and Acetaminophen for Acute Pain Management After Third-Molar Extractions: Translating Clinical Research to Dental Practice https://doi.org/10.1097/mlr.0b013e3182a95d86 https://doi.org/10.1111/acem.12328 https://doi.org/10.1002/14651858.cd004959.pub4 https://doi.org/10.1016/j.spinee.2013.08.049 https://doi.org/10.1002/14651858.cd003113.pub3 https://doi.org/10.1002/14651858.cd003115.pub4 https://doi.org/10.14219/jada.archive.2013.0207 Long-Term Opioid Treatment of Chronic Nonmalignant Pain: Unproven Efficacy and Neglected Safety? Opioid Pharmacotherapy for Chronic Non-Cancer Pain in the United States: A Research Guideline for Developing an Evidence-Base Long-Term Opioid Management for Chronic Noncancer Pain The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop Opioids for Chronic Noncancer Pain: A Position Paper of the American Academy Of Neurology supra Opioid Complications and Side Effects A Comprehensive Review of Opioid-Induced Hyperalgesia https://doi.org/10.2147/jpr.s47182 https://doi.org/10.1016/j.jpain.2010.02.019 https://doi.org/10.1002/14651858.cd006605.pub2 https://doi.org/10.7326/m14-2559 https://doi.org/10.1212/wnl.0000000000000839 Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain: A Systematic Review and Data Synthesis Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States Increases in Drug and Opioid Overdose Deaths — United States, 2000– 2014 Id. Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths Relationship of Opioid Prescription Sales and Overdoses, North Carolina supra Number and Age-Adjusted Rates of Drug- Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 2000–2014 supra Relationship Between Nonmedical Prescription-Opioid Use and Heroin Use Trends in Long-term Opioid Therapy for Chronic Non-Cancer Pain See, e.g. Pain Management, Controlled Substances, and State Medical Board Policy: A Decade of Change https://doi.org/10.1097/01.j.pain.0000460357.01998.f1 https://doi.org/10.1111/j.1526-4637.2011.01075.x https://doi.org/10.1001/jama.2011.370 https://doi.org/10.1016/j.drugalcdep.2013.01.006 https://doi.org/10.1056/nejmc1601875 http://doi.org/10.1002/pds.1833 https://doi.org/10.1016/s0885-3924(01)00403-1 The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction see The Promotion and Marketing of Oxycontin: Commercial Triumph, Public Health Tragedy In Guilty Plea, OxyContin Maker to Pay $600 Million Form 10-Q Insys Therapeutics, Inc. Judge Halts Counties' Lawsuit Against 5 Narcotic Drug Manufacturers see Physician Continuing Education to Reduce Opioid Misuse, Abuse, and Overdose: Many Opportunities, Few Requirements https://doi.org/10.1146/annurev-publhealth-031914-122957 https://doi.org/10.2105/ajph.2007.131714 https://doi.org/10.1016/j.drugalcdep.2016.04.002 A. The Burden of Untreated Opioid Addiction Physician Continuing Education to Reduce Opioid Misuse, Abuse, and Overdose: Many Opportunities, Few Requirements Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States Id. See, e.g., Economic Impact of Opioid Abuse, Dependence, and Misuse The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals See The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals https://doi.org/10.1016/j.drugalcdep.2016.04.002 https://doi.org/10.1111/j.1526-4637.2011.01075.x https://doi.org/10.3810/pgm.2014.07.2783 https://doi.org/10.1111/pme.12768 B. Medication Assisted Treatment (“MAT”) Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States 2006–2012 supra Changes in Substance Abuse Treatment Use Among Individuals with Opioid Use Disorders in the United States, 2004-2013 Id. See, e.g., See generally https://doi.org/10.1093/cid/ciu643 https://doi.org/10.1001/jama.2015.10345 see also see also A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence see also See Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions supra See Deaths During Methadone Maintenance Methadone Maintenance: The Basics Buprenorphine: A Drug You Need to Know About https://doi.org/10.1056/nejm200011023431802 https://doi.org/10.1097/hrp.0000000000000075 https://doi.org/10.1097/01.eem.0000351378.22473.93 https://doi.org/10.1097/01.eem.0000345622.44884.91 https://doi.org/10.1097/01.eem.0000342736.85273.cb Id. supra supra supra Methadone Maintenance: The Basics supra Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995-2009 Methadone Maintenance and Addicts’ Risk of Fatal Heroin Overdose The Effectiveness of Opioid Maintenance Treatment in Prison Settings: A Systematic Review https://doi.org/10.1056/nejmp1402780 https://doi.org/10.2105/ajph.2012.301049 https://doi.org/10.3109/10826089609045806 https://doi.org/10.1111/j.1360-0443.2011.03676.x C. Federal Legal Regulation of MAT: Historical Context Adoption and Implementation of Medications in Addiction Treatment Programs supra Failure of Physicians to Prescribe Pharmacotherapies for Addiction: Regulatory Restrictions and Physician Resistance Id. supra Id. See From Morphine Clinics to Buprenorphine: Regulating Opioid Agonist Treatment of Addiction in the United States https://doi.org/10.1097/adm.0b013e3181d41ddb https://doi.org/10.1016/s0376-8716(03)00055-3 Journal of the American Medical Association A Medical Treatment for Diacetylmorphine (Heroin) Addiction A Clinical Trial with Methadone Hydrochloride See Understanding FDA Regulatory Requirements for Investigational New Drug Applications for Sponsor-Investigators supra supra Id. supra supra not supra Id. supra https://doi.org/10.1001/jama.1965.03090080008002 https://doi.org/10.2310/jim.0b013e3181afdb26 D. Federal Regulation of Methadone supra Id . supra supra supra supra see also supra supra supra Prescriptions See ; Id. Id. Id. Id. See See Id. See see id. program or practitioner See See id. See See See id. See id. Id. Id. Id. Id. Id. Id. Id. Id. Id. Id. Id. E. Federal Regulation of Buprenorphine Id. Buprenorphine: A Drug You Need to Know About supra See id. Id. Id Id. Id. Id. Id. F. Insurance Coverage of MAT Id. Id. Id. Id. see infra Id. Id. Id. See Equality Standards for Health Insurance Coverage: Will the Mental Health Parity and Addiction Equity Act End The Discrimination? See Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act Id. Id. Id. Id. see amended by Id. Id. Id. Id. Id The Effects of Federal Parity on Substance Use Disorder Treatment Access To Mental Health Care Increased But Not For Substance Use, While Disparities Remain https://doi.org/10.1377/hlthaff.2016.0098 A. Access to Emergency Overdose Treatment supra Management of Common Opioid-Induced Adverse Effects Drug makers stand firm on TV ad for opioid-induced constipation , Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report Mechanisms of Fatal Opioid Overdose See Opioids and the Control of Respiration Physiological and Pathological Responses to Hypoxia Increases in Drug and Opioid Overdose Deaths–United States, 2000-2014 https://doi.org/10.1200/jco.2001.19.9.2542 https://doi.org/10.1046/j.1360-0443.1999.9479612.x https://doi.org/10.1093/bja/aen094 https://doi.org/10.1016/s0002-9440(10)63747-9 See A Comprehensive Review of Naloxone for the Emergency Physician Id. Review of Naloxone Safety for Opioid Overdose: Practical Considerations for New Technology and Expanded Public Access see also Controlled Substances–Alphabetical Order Assessment of the Safety and Ease of Use of the Naloxone Auto- injector for the Reversal of Opioid Overdose see also Emergency Medical Services Naloxone Access: A National Systematic Legal Review Emergengy Medical Services Naloxone Access Bologna-Naloxone Supplied to Italian Heroin Addicts Take Home Naloxone and the Prevention of Deaths from Opiate Overdose: Two Pilot Schemes Preliminary Evidence of Health Care Provider Support for Naloxone Prescription as Overdose Fatality Prevention Strategy in New York City Community-Based Opioid Overdose Prevention Programs Providing Naloxone–United States, 2010 https://doi.org/10.1016/0735-6757(94)90033-7 https://doi.org/10.1177/2042098614564776 https://doi.org/10.2147/oaem.s82133 https://doi.org/10.1111/acem.12485 https://doi.org/10.1016/s0140-6736(05)61528-0 https://doi.org/10.1136/bmj.322.7291.895 http://doi.org/10.1093/jurban/jtg031 Opioid Overdose Prevention Programs Providing Naloxone to Laypersons–United States, 2014 Id. Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists Orienting Patients to Greater Opioid Safety: Models of Community Pharmacy-Based Naloxone see also State Legal Innovations to Encourage Naloxone Dispensing CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016 Opioid Overdose Rates and Implementation of Overdose Education and Nasal Naloxone Distribution in Massachusetts: Interrupted Time Series Analysis Id. See also Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain https://doi.org/10.1097/adm.0000000000000223 https://doi.org/10.1186/s12954-015-0058-x https://doi.org/10.1016/j.japh.2016.11.007 https://doi.org/10.1001/jama.2016.1464 https://doi.org/10.1136/bmj.f174 https://doi.org/10.1300/j069v25n03_11 https://doi.org/10.7326/m15-2771 B. Addressing Legal and Policy Barriers to Naloxone Access Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal Opioid Overdose Prevention and Naloxone Distribution in Rhode Island Overdose Rescues by Trained and Untrained Participants and Change in Opioid Use Among Substance-Using Participants in Overdose Education and Naloxone Distribution Programs: A Retrospective Cohort Study See prescribe Physicians' Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities Legal Changes to Increase Access to Naloxone for Opioid Overdose Reversal in the United States https://doi.org/10.7326/0003-4819-158-1-201301010-00003 https://doi.org/10.1186/1471-2458-14-297 https://doi.org/10.1007/s11524-006-9120-z https://doi.org/10.1016/j.drugalcdep.2015.10.013 1. Immunity for Naloxone Prescribing, Dispensing, and Administration Changing Law from Barrier to Facilitator of Opioid Overdose Prevention Legal Aspects of Providing Naloxone to Heroin Users in the United States Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose Stopping an Invisible Epidemic See also Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration Physicians' Perceptions of the Risk of Being Sued Physicians' Fears of Malpractice Lawsuits are Not Assuaged by Tort Reforms https://doi.org/10.1111/jlme.12035 https://doi.org/10.1016/s0955-3959(01)00080-9 https://doi.org/10.2105/ajph.2015.302638 https://doi.org/10.1215/03616878-17-3-463 https://doi.org/10.1377/hlthaff.2010.0135 2. Prescribing Outside of the Traditional Prescriber Relationship See see Id. Stopping an Invisible Epidemic supra See id. Id. Id. Id. 3. Overdose Good Samaritan Laws See Emergengy Medical Services Naloxone Access supra Cost-Effectiveness of Pneumococcal and Influenza Vaccination Standing Order Programs see also Are Standing Order Programs Associated With Influenza Vaccination?–NNHS, 2004 Id. Luke Colossians Luke Id. Id. Id . see Is There a Doctor (and a Lawyer) in the House? Why our Good Samaritan https://doi.org/10.1016/j.jamda.2009.12.091 4. Over the Counter Access to Naloxone Laws are Doing More Harm Than Good for a National Public Health Security Strategy: A Fifty- State Survey See, e.g. ‘We can’t arrest our way out of it’: Chesterfield Police Explore New Ways to Combat Heroin Epidemic see also Upton: We Can’t Arrest Our Way Out of Opioid Epidemic Id. Id. Id. Id. Id. See "Over the Counter" Naloxone Access, Explained See Australia Reschedules Naloxone for Opioid Overdose See The Availability of Take-Home Naloxone in Canada See Guidance: Widening the Availability of Naloxone Take-Home Naloxone for Opioid Overdose in People Who Use Drugs https://doi.org/10.5694/mja15.01181 see THE FDA AND PLAN B: The Legislative History of the Durham- Humphrey Amendments and the Consideration of Social Harms in the Rx-OTC Switch supra see also Regulatory Mechanisms for Marketing OTC Drug Products see also Small Business Assistance: Frequently Asked Questions on the Regulatory Process of Over-the-Counter (OTC) Drugs Introduction to Nonprescription Products . Id. Overview of the Over-The-Counter Drug Monograph Process See Id. See OTC naloxone? It's Possible See You Can Buy Insulin Without a Prescription, But Should You? See generally Changing the Status of Drugs from Prescription to Over-the- Counter Availability see supra see also Regulation of Nonprescription Products, See supra See id. id. id. supra Changing course: A new approach to opioid pain medication at FDA Epidemic: Responding to America's Prescription Drug Abuse Crisis https://doi.org/10.1056/nejmra011080 Overdose Death Rates Increases in Drug and Opioid Overdose Deaths–United States, 2000- 2014 What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose State Legal Restrictions and Prescription-Opioid Use among Disabled Adults Drug- poisoning Deaths Involving Heroin: United States, 2000-2013 See generally Increases in Drug and Opioid Overdose Deaths–United States, 2000-2014 Applying Farr's Law to Project the Drug Overdose Mortality Epidemic in the United States Effect of a "Pill Mill" Law on Opioid Prescribing and Utilization: The Case of Texas https://doi.org/10.1016/j.drugalcdep.2014.10.001 https://doi.org/10.1056/nejmsa1514387 https://doi.org/10.1016/j.drugalcdep.2015.12.025 See generally Physician Continuing Education to Reduce Opioid Misuse, Abuse, and Overdose: Many Opportunities, few Requirements Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths–United States, 2002-2014 See generally https://doi.org/10.1016/j.drugalcdep.2016.04.002